Potent, orally active and non-emetic phosphodiesterase-4 inhibitors.

被引：0
|
作者：
Guay, D [1 ]
机构：
[1] Merck Frosst Canada Inc, Merck Frosst Ctr Therapeut Res, Dept Med Chem, Pointe Claire, PQ H9R 4P8, Canada
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
211-MEDI
引用
收藏
页码：U39 / U40
页数：2
相关论文
共 50 条
  • [1] Discovery of L-791,943:: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor
    Guay, D
    Hamel, P
    Blouin, M
    Brideau, C
    Chan, CC
    Chauret, N
    Ducharme, Y
    Huang, Z
    Girard, M
    Jones, TR
    Laliberté, F
    Masson, P
    McAuliffe, M
    Piechuta, H
    Silva, J
    Young, RN
    Girard, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (11) : 1457 - 1461
  • [2] 2,3-disubstituted pyridine derivatives as non-emetic phosphodiesterase type 4 inhibitors.
    Nigo, T
    Nakamura, S
    Yoshioka, S
    Teranishi, Y
    Itch, MN
    Kawasaki, M
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U950 - U951
  • [3] ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity
    Kobayashi, Miki
    Kubo, Satoshi
    Iwata, Masahiro
    Ohtsu, Yoshiaki
    Takahashi, Koichiro
    Shimizu, Yasuaki
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (06) : 732 - 739
  • [4] Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors
    Côté, B
    Frenette, R
    Prescott, S
    Blouin, M
    Brideau, C
    Ducharme, Y
    Friesen, RW
    Laliberté, F
    Masson, P
    Styhler, A
    Girard, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 741 - 744
  • [5] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
    Tong, YS
    Wang, L
    Hasvold, L
    Leonard, N
    Li, TM
    Li, Q
    Wang, WB
    Cohen, J
    Gu, WZ
    Zhang, HY
    Bauch, J
    Marsh, K
    Rosenberg, SH
    Lin, NH
    Sham, HL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
  • [6] Discovery of potent, selective, non-emetic PDE4 inhibitors based on a pyrrolidine core.
    Odingo, JO
    Oliver, AR
    Kesicki, EA
    Burgess, LE
    Gaudino, JJ
    Jones, ZS
    Newhouse, BJ
    Schlachter, ST
    Wang, S
    Hettel, C
    Stephan, TE
    Martins, TJ
    Fowler, KW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U38 - U38
  • [7] Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors
    Kawasaki, Motoji
    Fusano, Akira
    Nigo, Tomohiro
    Nakamura, Shunya
    Ito, Mari N.
    Teranishi, Yasuhiro
    Matsumoto, Satoshi
    Toda, Hiroshi
    Nomura, Naruaki
    Sumiyoshi, Takaaki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (12) : 2689 - 2692
  • [8] Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses
    Zhou, Zhong-Zhen
    Cheng, Yu-Fang
    Zou, Zheng-Qiang
    Ge, Bing-Chen
    Yu, Hui
    Huang, Cang
    Wang, Hai-Tao
    Yang, Xue-Mei
    Xu, Jiang-Ping
    [J]. ACS CHEMICAL NEUROSCIENCE, 2017, 8 (01): : 135 - 146
  • [9] DESIGN AND SYNTHESIS OF NOVEL POTENT, NON-PEPTIDE AND ORALLY ACTIVE RENIN INHIBITORS.
    Grutter, M.
    Maibaum, J.
    Rasetti, V.
    Rueger, H.
    Goschke, R.
    Mah, R.
    Cohen, N. C.
    Rahuel, J.
    Cumin, F.
    Wood, J.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C583 - C583
  • [10] Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors
    Kuemmerle, Arthur E.
    Schmitt, Martine
    Cardozo, Suzana V. S.
    Lugnier, Claire
    Villa, Pascal
    Lopes, Alexandra B.
    Romeiro, Nelilma C.
    Justiniano, Helene
    Martins, Marco A.
    Fraga, Carlos A. M.
    Bourguignon, Jean-Jacques
    Barreiro, Eliezer J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) : 7525 - 7545
12345